Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Aripiprazole
69%
Adverse Event
49%
Typical Antipsychotic
49%
Polypharmacy
46%
Clozapine
46%
Recurrent Disease
43%
Symptom
43%
Treatment-Resistant Schizophrenia
43%
Major Depression
32%
Remission
27%
Placebo
26%
Paliperidone
26%
Risperidone
26%
Cohort Study
25%
Diazepam
24%
Observational Study
23%
Depression
22%
Febrile Neutropenia
21%
Aspartate Aminotransferase
21%
Cisplatin
21%
Recurrence Risk
21%
Antidepressant
21%
Bipolar Mania
21%
Disease
21%
Lamictal
21%
Headache
21%
Bipolar I Disorder
21%
Olanzapine
21%
Drug Administration
21%
Hemoglobin A1c
21%
Fluorouracil
21%
High Density Lipoprotein Cholesterol
21%
Population Study
21%
Asenapine
21%
Monotherapy
21%
Controlled Release
21%
Vortioxetine
21%
Random Effects Model
19%
Mixed Anxiety and Depression
16%
Cariprazine
13%
Randomized Controlled Trial
10%
Chronic Kidney Failure
10%
Triacylglycerol
10%
Bipolar Disorder
10%
Metabolic Syndrome X
10%
Chronic Liver Disease
10%
Cross-Sectional Study
10%
Adverse Drug Reaction
10%
Alanine Aminotransferase
10%
Keyphrases
Japan
27%
Antipsychotics
25%
Vortioxetine
24%
Patients with Schizophrenia
21%
Febrile Neutropenia
21%
Older People
21%
Subjective Survey
21%
Newer Antidepressants
21%
Systematic Meta-analysis
21%
Bipolar Mania
21%
Long-acting Injectable Aripiprazole
21%
Neutrophil-lymphocyte Ratio
21%
Meta-analysis
21%
Long-acting Injection
21%
Muscle Injection
21%
Lamotrigine
21%
Enrichment Design
21%
Japanese Adverse Drug Event Report (JADER)
21%
5-fluorouracil (5-FU)
21%
Clozapine
21%
Deltoid Injection
21%
Cisplatin
21%
Trends Survey
21%
Major Depressive Disorder
21%
Monotherapy
21%
Treatment-resistant Schizophrenia
21%
Antipsychotic Polypharmacy
21%
Work Outcomes
21%
Mirror-image Study
21%
Antidepressants
21%
Left DLPFC
18%
High-dose Antipsychotics
16%
Confidence Interval
15%
Pharmacist-led
14%
Cariprazine
13%
Gluteal Injection
13%
Clozapine Discontinuation
13%
Risk Ratio
12%
Adverse Events
12%
Outpatient Department
10%
Social Rehabilitation
10%
Long-term Medication
10%
Poor Insight
10%
Psychiatric Treatment
10%
Release Agent
10%
Image Model
10%
Mirror Image
10%
Safety Correction
10%
Polypharmacy
9%
Placebo
9%